http://bio2rdf.org/drugbank_resource:DB01072_DB01198_nanopub.RAK_48BtrcMR5ieAP40loiMgpG_FjywL48RqTfpvEpy8M#head http://bio2rdf.org/drugbank_resource:DB01072_DB01198_nanopub.RAK_48BtrcMR5ieAP40loiMgpG_FjywL48RqTfpvEpy8M http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB01072_DB01198_nanopub.RAK_48BtrcMR5ieAP40loiMgpG_FjywL48RqTfpvEpy8M#assertion http://bio2rdf.org/drugbank_resource:DB01072_DB01198_nanopub.RAK_48BtrcMR5ieAP40loiMgpG_FjywL48RqTfpvEpy8M http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB01072_DB01198_nanopub.RAK_48BtrcMR5ieAP40loiMgpG_FjywL48RqTfpvEpy8M#provenance http://bio2rdf.org/drugbank_resource:DB01072_DB01198_nanopub.RAK_48BtrcMR5ieAP40loiMgpG_FjywL48RqTfpvEpy8M http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB01072_DB01198_nanopub.RAK_48BtrcMR5ieAP40loiMgpG_FjywL48RqTfpvEpy8M#publicationInfo http://bio2rdf.org/drugbank_resource:DB01072_DB01198_nanopub.RAK_48BtrcMR5ieAP40loiMgpG_FjywL48RqTfpvEpy8M http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB01072_DB01198_nanopub.RAK_48BtrcMR5ieAP40loiMgpG_FjywL48RqTfpvEpy8M#assertion http://bio2rdf.org/drugbank:DB01072 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB01072_DB01198 http://bio2rdf.org/drugbank:DB01198 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB01072_DB01198 http://bio2rdf.org/drugbank_resource:DB01072_DB01198 http://purl.org/dc/terms/identifier drugbank_resource:DB01072_DB01198 http://bio2rdf.org/drugbank_resource:DB01072_DB01198 http://purl.org/dc/terms/title DDI between Atazanavir and Zopiclone - Atazanavir, a strong CYP3A4 inhibitor, may increase the serum concentration of zopiclone by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zopiclone if atazanavir is initiated, discontinued or dose changed. http://bio2rdf.org/drugbank_resource:DB01072_DB01198 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB01072_DB01198 http://www.w3.org/2000/01/rdf-schema#label DDI between Atazanavir and Zopiclone - Atazanavir, a strong CYP3A4 inhibitor, may increase the serum concentration of zopiclone by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zopiclone if atazanavir is initiated, discontinued or dose changed. [drugbank_resource:DB01072_DB01198] http://bio2rdf.org/drugbank_resource:DB01072_DB01198_nanopub.RAK_48BtrcMR5ieAP40loiMgpG_FjywL48RqTfpvEpy8M#provenance http://bio2rdf.org/drugbank_resource:DB01072_DB01198_nanopub.RAK_48BtrcMR5ieAP40loiMgpG_FjywL48RqTfpvEpy8M#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB01072_DB01198_nanopub.RAK_48BtrcMR5ieAP40loiMgpG_FjywL48RqTfpvEpy8M#publicationInfo http://bio2rdf.org/drugbank_resource:DB01072_DB01198_nanopub.RAK_48BtrcMR5ieAP40loiMgpG_FjywL48RqTfpvEpy8M#signature.MC4CFQCJslU8Qx1s http://purl.org/nanopub/x/hasPublicKey MIIBtzCCASwGByqGSM44BAEwggEfAoGBAP1/U4EddRIpUt9KnC7s5Of2EbdSPO9EAMMeP4C2USZpRV1AIlH7WT2NWPq/xfW6MPbLm1Vs14E7gB00b/JmYLdrmVClpJ+f6AR7ECLCT7up1/63xhv4O1fnxqimFQ8E+4P208UewwI1VBNaFpEy9nXzrith1yrv8iIDGZ3RSAHHAhUAl2BQjxUjC8yykrmCouuEC/BYHPUCgYEA9+GghdabPd7LvKtcNrhXuXmUr7v6OuqC+VdMCz0HgmdRWVeOutRZT+ZxBxCBgLRJFnEj6EwoFhO3zwkyjMim4TwWeotUfI0o4KOuHiuzpnWRbqN/C/ohNWLx+2J6ASQ7zKTxvqhRkImog9/hWuWfBpKLZl6Ae1UlZAFMO/7PSSoDgYQAAoGAETGrDm8R3KfndKRj7ttr3jVhhstI6/2Ey0ER9F5kdx7Hrd6eolq7yWzPzf2H754tdZxICzxYcdawBbL2ZUzFjWwXTNUQC3+e6evKPJyNELubnZcA+8TxIIwicBnw3Ku6mSeI8SUVr5SBV1VeJoSu/ahldv562IdBR8IagmzuT3Y= http://bio2rdf.org/drugbank_resource:DB01072_DB01198_nanopub.RAK_48BtrcMR5ieAP40loiMgpG_FjywL48RqTfpvEpy8M#signature.MC4CFQCJslU8Qx1s http://purl.org/nanopub/x/hasSignature MC4CFQCJslU8Qx1saNJSYRGpGSsHgf0/wQIVAIhNtwvl1wAX3SRWhRe/adYv7WUd http://bio2rdf.org/drugbank_resource:DB01072_DB01198_nanopub.RAK_48BtrcMR5ieAP40loiMgpG_FjywL48RqTfpvEpy8M#signature.MC4CFQCJslU8Qx1s http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB01072_DB01198_nanopub.RAK_48BtrcMR5ieAP40loiMgpG_FjywL48RqTfpvEpy8M http://purl.org/dc/terms/created 2018-03-30T11:12:38.181+02:00 http://bio2rdf.org/drugbank_resource:DB01072_DB01198_nanopub.RAK_48BtrcMR5ieAP40loiMgpG_FjywL48RqTfpvEpy8M http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB01072_DB01198_nanopub.RAK_48BtrcMR5ieAP40loiMgpG_FjywL48RqTfpvEpy8M http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB01072_DB01198_nanopub.RAK_48BtrcMR5ieAP40loiMgpG_FjywL48RqTfpvEpy8M#signature.MC4CFQCJslU8Qx1s http://bio2rdf.org/drugbank_resource:DB01072_DB01198_nanopub.RAK_48BtrcMR5ieAP40loiMgpG_FjywL48RqTfpvEpy8M http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234